Search alternatives:
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
point decrease » point increase (Expand Search)
Showing 1 - 20 results of 5,496 for search '(( significantly advanced decrease ) OR ( significant ((point decrease) OR (mean decrease)) ))', query time: 0.46s Refine Results
  1. 1
    Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest.

    Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest. by Helal El-Zaatari (20442243)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session.

    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Effects of GJE extract treatment decreased serum ALT and AST levels.

    Effects of GJE extract treatment decreased serum ALT and AST levels. by Natnicha Suttawong (22367172)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Effects of GJE extract treatment decreased accumulation of Col1a1.

    Effects of GJE extract treatment decreased accumulation of Col1a1. by Natnicha Suttawong (22367172)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Effects of GJE extract treatment decreased expression of NF-kB p65.

    Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Middle cerebral artery mean flow velocity at three time points.

    Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 7
    PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity.

    PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

    Published 2025
    Save to List
    Saved in:
  8. 8
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 9
    Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit.

    Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit. by Jung-Tae Kim (8997767)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: